se of Advanced Ultrasound in treatment of Breast cancer.
Not Applicable
- Conditions
- Health Condition 1: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2024/04/065044
- Lead Sponsor
- Dr Neha S Hubli
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All breast cancer patients planned for surgical excision after undergoing neo adjuvant chemotherapy (NACT).
Exclusion Criteria
Patients scheduled for upfront surgery or not planned for surgery post full course of NACT.
Patients with recurrent/ metastatic breast cancer.
Patient with loss to follow up due to change of primary care hospital or treatment discontinuation or death.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response to NACT: Yes/No (Based on post-surgical HPE)Timepoint: 20-24 weeks post 1st cycle of NACT or 2-3 weeks post surgical resection of tumor
- Secondary Outcome Measures
Name Time Method Shear wave elastography parameter(s) that showed significance & their recommended cutoffs. <br/ ><br> <br/ ><br>Comparison of clinicopathological features & treatment regimen with respect to SWE parameters in responders & non-responders.Timepoint: 31st March 2026 or at end point of entire study